Research on vaccines during pregnancy

Reference values for vital signs and laboratory assessments

Jeanne S. Sheffield, Flor M. Munoz, Richard H. Beigi, Sonja A. Rasmussen, Kathryn M. Edwards, Jennifer S. Read, R. Phillips Heine, Kevin A. Ault, Geeta K. Swamy, Indira Jevaji, Catherine Y. Spong, Kimberly Fortner, Shital M. Patel, Mirjana Nesin

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases, National Institutes of Health organized a series of conferences, "Enrolling Pregnant Women in Clinical Trials of Vaccines and Therapeutics", to discuss enrollment and safety assessments of pregnant women in clinical trials of vaccines. Experts in obstetrics, maternal-fetal medicine, infectious diseases, pediatrics, neonatology, genetics, vaccinology and clinical trial design were charged with identifying normal ranges for vital signs and laboratory assessments in pregnancy. A grading system for adverse events was then developed.

Original languageEnglish (US)
Pages (from-to)4264-4273
Number of pages10
JournalVaccine
Volume31
Issue number40
DOIs
StatePublished - Sep 13 2013

Fingerprint

Vital Signs
normal values
infectious diseases
clinical trials
Reference Values
Vaccines
Clinical Trials
pregnancy
pregnant women
vaccines
Pregnancy
Pregnant Women
Infectious Disease Medicine
National Institute of Allergy and Infectious Diseases (U.S.)
Research
Neonatology
National Institutes of Health
safety assessment
National Institutes of Health (U.S.)
vaccine development

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Sheffield, J. S., Munoz, F. M., Beigi, R. H., Rasmussen, S. A., Edwards, K. M., Read, J. S., ... Nesin, M. (2013). Research on vaccines during pregnancy: Reference values for vital signs and laboratory assessments. Vaccine, 31(40), 4264-4273. https://doi.org/10.1016/j.vaccine.2013.07.031

Research on vaccines during pregnancy : Reference values for vital signs and laboratory assessments. / Sheffield, Jeanne S.; Munoz, Flor M.; Beigi, Richard H.; Rasmussen, Sonja A.; Edwards, Kathryn M.; Read, Jennifer S.; Heine, R. Phillips; Ault, Kevin A.; Swamy, Geeta K.; Jevaji, Indira; Spong, Catherine Y.; Fortner, Kimberly; Patel, Shital M.; Nesin, Mirjana.

In: Vaccine, Vol. 31, No. 40, 13.09.2013, p. 4264-4273.

Research output: Contribution to journalArticle

Sheffield, JS, Munoz, FM, Beigi, RH, Rasmussen, SA, Edwards, KM, Read, JS, Heine, RP, Ault, KA, Swamy, GK, Jevaji, I, Spong, CY, Fortner, K, Patel, SM & Nesin, M 2013, 'Research on vaccines during pregnancy: Reference values for vital signs and laboratory assessments', Vaccine, vol. 31, no. 40, pp. 4264-4273. https://doi.org/10.1016/j.vaccine.2013.07.031
Sheffield JS, Munoz FM, Beigi RH, Rasmussen SA, Edwards KM, Read JS et al. Research on vaccines during pregnancy: Reference values for vital signs and laboratory assessments. Vaccine. 2013 Sep 13;31(40):4264-4273. https://doi.org/10.1016/j.vaccine.2013.07.031
Sheffield, Jeanne S. ; Munoz, Flor M. ; Beigi, Richard H. ; Rasmussen, Sonja A. ; Edwards, Kathryn M. ; Read, Jennifer S. ; Heine, R. Phillips ; Ault, Kevin A. ; Swamy, Geeta K. ; Jevaji, Indira ; Spong, Catherine Y. ; Fortner, Kimberly ; Patel, Shital M. ; Nesin, Mirjana. / Research on vaccines during pregnancy : Reference values for vital signs and laboratory assessments. In: Vaccine. 2013 ; Vol. 31, No. 40. pp. 4264-4273.
@article{55425d4f17b14c0e9a4ae4ec9815b077,
title = "Research on vaccines during pregnancy: Reference values for vital signs and laboratory assessments",
abstract = "The Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases, National Institutes of Health organized a series of conferences, {"}Enrolling Pregnant Women in Clinical Trials of Vaccines and Therapeutics{"}, to discuss enrollment and safety assessments of pregnant women in clinical trials of vaccines. Experts in obstetrics, maternal-fetal medicine, infectious diseases, pediatrics, neonatology, genetics, vaccinology and clinical trial design were charged with identifying normal ranges for vital signs and laboratory assessments in pregnancy. A grading system for adverse events was then developed.",
author = "Sheffield, {Jeanne S.} and Munoz, {Flor M.} and Beigi, {Richard H.} and Rasmussen, {Sonja A.} and Edwards, {Kathryn M.} and Read, {Jennifer S.} and Heine, {R. Phillips} and Ault, {Kevin A.} and Swamy, {Geeta K.} and Indira Jevaji and Spong, {Catherine Y.} and Kimberly Fortner and Patel, {Shital M.} and Mirjana Nesin",
year = "2013",
month = "9",
day = "13",
doi = "10.1016/j.vaccine.2013.07.031",
language = "English (US)",
volume = "31",
pages = "4264--4273",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "40",

}

TY - JOUR

T1 - Research on vaccines during pregnancy

T2 - Reference values for vital signs and laboratory assessments

AU - Sheffield, Jeanne S.

AU - Munoz, Flor M.

AU - Beigi, Richard H.

AU - Rasmussen, Sonja A.

AU - Edwards, Kathryn M.

AU - Read, Jennifer S.

AU - Heine, R. Phillips

AU - Ault, Kevin A.

AU - Swamy, Geeta K.

AU - Jevaji, Indira

AU - Spong, Catherine Y.

AU - Fortner, Kimberly

AU - Patel, Shital M.

AU - Nesin, Mirjana

PY - 2013/9/13

Y1 - 2013/9/13

N2 - The Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases, National Institutes of Health organized a series of conferences, "Enrolling Pregnant Women in Clinical Trials of Vaccines and Therapeutics", to discuss enrollment and safety assessments of pregnant women in clinical trials of vaccines. Experts in obstetrics, maternal-fetal medicine, infectious diseases, pediatrics, neonatology, genetics, vaccinology and clinical trial design were charged with identifying normal ranges for vital signs and laboratory assessments in pregnancy. A grading system for adverse events was then developed.

AB - The Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases, National Institutes of Health organized a series of conferences, "Enrolling Pregnant Women in Clinical Trials of Vaccines and Therapeutics", to discuss enrollment and safety assessments of pregnant women in clinical trials of vaccines. Experts in obstetrics, maternal-fetal medicine, infectious diseases, pediatrics, neonatology, genetics, vaccinology and clinical trial design were charged with identifying normal ranges for vital signs and laboratory assessments in pregnancy. A grading system for adverse events was then developed.

UR - http://www.scopus.com/inward/record.url?scp=84882882133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882882133&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2013.07.031

DO - 10.1016/j.vaccine.2013.07.031

M3 - Article

VL - 31

SP - 4264

EP - 4273

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 40

ER -